Literature DB >> 18361877

[Isolation of Nocardia species in patients with cystic fibrosis].

M Isabel Barrio1, M Carmen Martínez, Concepción Prados, Rosa M Girón, Luis Maiz, M Teresa Martínez.   

Abstract

The isolation of Nocardia species from the respiratory secretions of patients with cystic fibrosis presents problems with important clinical implications. From the sputum culture of a total of 387 patients with cystic fibrosis, Nocardia species was isolated in 9 cases (2%; 8 females and 1 male) with a mean (SD) age of 17 (7) years. Sixty-seven percent of the patients were asymptomatic and no relevant radiographic or analytical changes were detected. In only 3 patients was of Nocardia species isolated again in successive samples. Two patients were not treated, 7 were treated with cotrimoxazole and 3 with minocycline; in 2 cases therapy was intravenous. After a mean follow-up of 48 (33) months, all patients had improved. Isolation of Nocardia species from the secretions of patients with cystic fibrosis does not necessarily imply infection and the need for treatment should be assessed on an individual basis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18361877     DOI: 10.1016/s1579-2129(08)60021-x

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  8 in total

Review 1.  Disseminated nocardiosis caused by Nocardia elegans: a case report and review of the literature.

Authors:  Yi You; Wenchief Chen; Baiyu Zhong; Ziqiang Song; Xichuan Yang
Journal:  Infection       Date:  2018-05-08       Impact factor: 3.553

2.  A French multicentric study and review of pulmonary Nocardia spp. in cystic fibrosis patients.

Authors:  Verónica Rodriguez-Nava; Stéphane Durupt; Sandra Chyderiotis; Anne-Marie Freydière; Judith Karsenty; Michèle de Montclos; Philippe Reix; Isabelle Durieu; Raphaele Nove-Josserand; Raphael Chiron; François Bremont; Laurent Têtu; Marlène Murris; Dominique Terru; Sylvain Godreuil; Emmanuelle Bergeron; Jean Freney; Patrick Boiron; François Vandenesch; Hélène Marchandin; Christine Segonds; Anne Doléans-Jordheim
Journal:  Med Microbiol Immunol       Date:  2014-10-26       Impact factor: 3.402

3.  Nocardia farcinica lung infection in a patient with cystic fibrosis: a case report.

Authors:  Fadi Bittar; Nathalie Stremler; Jean-Pierre Audié; Jean-Christophe Dubus; Jacques Sarles; Didier Raoult; Jean-Marc Rolain
Journal:  J Med Case Rep       Date:  2010-03-08

4.  Nocardia Colonization: A Risk Factor for Lung Deterioration in Cystic Fibrosis Patients?

Authors:  Adi Dagan; Nathan Keller; Daphna Vilozni; Reut Ramon-Saraf; Bat-El Bar; Ifat Sarouk; Moshe Ashkenazi; Moran Lavie; Ori Efrati
Journal:  Med Sci Monit       Date:  2015-06-30

5.  Pulmonary nocardiosis in an immunocompetent patient with cystic fibrosis.

Authors:  Lucy Schoen; Jonathan D Santoro; Carlos Milla; Sumit Bhargava
Journal:  Case Rep Pulmonol       Date:  2015-04-15

6.  Clinical significance, antimicrobial susceptibility and molecular identification of Nocardia species isolated from children with cystic fibrosis.

Authors:  Ana Betrán; M Cruz Villuendas; Antonio Rezusta; Javier Pereira; M José Revillo; Verónica Rodríguez-Nava
Journal:  Braz J Microbiol       Date:  2016-04-19       Impact factor: 2.476

7.  Mixed Infection of Cytomegalovirus and Pulmonary Nocardiosis Caused by Nocardia elegans Diagnosed Using Nanopore Sequencing Technology.

Authors:  Chie Watanabe; Yoshifumi Kimizuka; Yuji Fujikura; Takaaki Hamamoto; Akira Watanabe; Takashi Yaguchi; Tomoya Sano; Ryohei Suematsu; Yoshiki Kato; Jun Miyata; Susumu Matsukuma; Akihiko Kawana
Journal:  Intern Med       Date:  2021-10-26       Impact factor: 1.282

8.  A case of Nocardia transvalensis pneumonia in a 19-year-old cystic fibrosis patient.

Authors:  Avinash Aravantagi; Kamakshya P Patra; Marlene Broussard; Kimberly Jones
Journal:  Lung India       Date:  2012-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.